Celularity Inc.: 10-Q filed 2020-11-16
What Celularity Inc. reported in its quarterly report filed 2020-11-16 (fiscal Q3 2020): 20 published measures, 62 facts as tagged in accession 0001213900-20-037167.
This filing
- Form
- 10-Q (quarterly report)
- Filed
- 2020-11-16
- Fiscal period
- fiscal Q3 2020
- Accession
- 0001213900-20-037167 on SEC EDGAR
Values are as tagged in this filing. A later filing can restate them; each measure links to its history page, which shows the latest-filed value per period. All Celularity Inc. filings.
Reported measures
Total assets
Resources recognized on the balance sheet. Book assets are not the market value of the business.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2020-09-30 | 292,365,026 | USD | |
| At 2019-12-31 | 291,605,350 | USD |
Total liabilities
Recognized obligations at the reporting date. The definition and scope differ from interest-bearing debt.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2020-09-30 | 10,957,695 | USD | |
| At 2019-12-31 | 11,041,594 | USD |
Stockholders equity
The reported residual interest after liabilities. It is an accounting amount, not market capitalization.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2020-09-30 | 5,000,004 | USD | |
| At 2020-06-30 | 5,000,007 | USD | |
| At 2020-03-31 | 5,000,008 | USD | |
| At 2019-12-31 | 5,000,001 | USD | |
| At 2019-09-30 | 5,000,001 | USD | |
| At 2019-06-30 | 5,000,001 | USD | |
| At 2019-03-31 | 23,781 | USD | |
| At 2018-12-31 | 23,902 | USD |
Cash and cash equivalents
Cash and qualifying short-term liquid investments under the filer’s accounting policy. Restricted cash and longer-term investments may be reported separately.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2020-09-30 | 454,497 | USD | |
| At 2019-12-31 | 917,007 | USD | |
| At 2019-09-30 | 1,024,811 | USD | |
| At 2018-12-31 | 24,707 | USD |
Net income or loss
Reported profit or loss for the period. Check the filing for attribution, exceptional items and discontinued operations before comparing companies.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2020-07-01 to 2020-09-30 | -37,524 | USD | 92 |
| 2020-01-01 to 2020-09-30 | 843,575 | USD | 274 |
| 2019-07-01 to 2019-09-30 | 1,121,167 | USD | 92 |
| 2019-01-01 to 2019-09-30 | 1,755,706 | USD | 273 |
Operating cash flow
Cash generated or used by operating activities. Working-capital timing can make this differ substantially from reported income.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2020-01-01 to 2020-09-30 | -938,713 | USD | 274 |
| 2019-01-01 to 2019-09-30 | -874,029 | USD | 273 |
Financing cash flow
Net cash from financing activities, including borrowing, repayments and transactions with owners. A positive amount does not establish operating profitability.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2019-01-01 to 2019-09-30 | 288,839,133 | USD | 273 |
Investing cash flow
Net cash from investing activities, including asset purchases, disposals and investment transactions. This differs from capital expenditure payments alone.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2020-01-01 to 2020-09-30 | 476,203 | USD | 274 |
| 2019-01-01 to 2019-09-30 | -286,965,000 | USD | 273 |
Retained earnings or deficit
Accumulated undistributed earnings or deficit at the reporting date. This balance is not cash available for distribution.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2020-09-30 | 3,355,448 | USD | |
| At 2019-12-31 | 2,511,873 | USD |
Income tax expense or benefit
Current and deferred income tax expense or benefit for continuing operations. This accounting expense differs from cash taxes paid.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2020-07-01 to 2020-09-30 | -9,964 | USD | 92 |
| 2020-01-01 to 2020-09-30 | 224,505 | USD | 274 |
| 2019-07-01 to 2019-09-30 | 298,032 | USD | 92 |
| 2019-01-01 to 2019-09-30 | 466,707 | USD | 273 |
Operating income or loss
Operating revenue less operating expenses for the reporting period. It excludes items outside the reported operating result and is not free cash flow.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2020-07-01 to 2020-09-30 | -208,305 | USD | 92 |
| 2020-01-01 to 2020-09-30 | -658,177 | USD | 274 |
| 2019-07-01 to 2019-09-30 | -202,004 | USD | 92 |
| 2019-01-01 to 2019-09-30 | -317,375 | USD | 273 |
Current assets
Assets classified as current under the normal operating cycle or one-year boundary. Not all current assets can be converted immediately into cash.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2020-09-30 | 520,432 | USD | |
| At 2019-12-31 | 1,009,157 | USD |
Current liabilities
Obligations classified as current under the operating-cycle or one-year boundary. The balance includes more than short-term borrowing.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2020-09-30 | 141,314 | USD | |
| At 2019-12-31 | 229,094 | USD |
Additional paid-in capital
Capital contributed above par value under this concept. It records historical contributions, not the current value of the equity or cash on hand.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2020-09-30 | 1,643,686 | USD | |
| At 2019-12-31 | 2,487,262 | USD |
Net deferred tax liabilities
Deferred tax liabilities net of related assets under this concept. The amount reflects timing differences and is not tax currently due.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2020-09-30 | 3,881 | USD |
Pre-tax income or loss from continuing operations
Income or loss from continuing operations before income taxes and noncontrolling interests. It excludes discontinued operations and is not net income.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2020-07-01 to 2020-09-30 | -47,488 | USD | 92 |
| 2020-01-01 to 2020-09-30 | 1,068,080 | USD | 274 |
| 2019-07-01 to 2019-09-30 | 1,419,199 | USD | 92 |
| 2019-01-01 to 2019-09-30 | 2,222,413 | USD | 273 |
Profit or loss including noncontrolling interests
Net income or loss including the portion attributable to noncontrolling interests. It can differ from the net income attributable to the parent that per-share figures use.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2020-07-01 to 2020-09-30 | -37,524 | USD | 92 |
| 2020-04-01 to 2020-06-30 | -143,588 | USD | 91 |
| 2020-01-01 to 2020-03-31 | 1,024,687 | USD | 91 |
| 2019-07-01 to 2019-09-30 | 1,121,167 | USD | 92 |
| 2019-04-01 to 2019-06-30 | 634,660 | USD | 91 |
| 2019-01-01 to 2019-03-31 | -121 | USD | 90 |
Net income available to common stockholders
Net income after preferred dividends and similar adjustments, the numerator for basic earnings per share. It can be lower than reported net income.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2020-07-01 to 2020-09-30 | -151,964 | USD | 92 |
| 2020-01-01 to 2020-09-30 | -437,210 | USD | 274 |
| 2019-07-01 to 2019-09-30 | -87,836 | USD | 92 |
| 2019-01-01 to 2019-09-30 | -117,932 | USD | 273 |
Nonoperating income or expense
Total nonoperating income or expense, which can include interest, investment results and other items. A positive value is not operating profit.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2020-07-01 to 2020-09-30 | 160,817 | USD | 92 |
| 2020-01-01 to 2020-09-30 | 1,726,257 | USD | 274 |
| 2019-07-01 to 2019-09-30 | 1,621,203 | USD | 92 |
| 2019-01-01 to 2019-09-30 | 2,539,788 | USD | 273 |
Deferred income tax expense or benefit
The deferred portion of income tax expense or benefit, arising from timing differences. It is not tax paid in the period.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2020-01-01 to 2020-09-30 | 5,534 | USD | 274 |
| 2019-01-01 to 2019-09-30 | 39,466 | USD | 273 |
Inspect the source
- Entity
- Celularity Inc. / CIK 0001752828
- Captured
- 2026-09-21T17:29:07.737Z
- SEC response SHA-256
732b52ad9f2d29e719fef49cad3d40c16039c1cb3073b05f4cf01eb23c287447
Current SEC company facts · Download the original response snapshot (gzip) · Download the selected JSON
Every published concept a filing tagged, with the periods it covered, as reported in that filing at capture time. Forms 10-K, 10-K/A, 10-Q, 10-Q/A, 20-F, 20-F/A, 40-F, 40-F/A. A filing page needs at least 8 published concepts. Later filings can restate these values; the company history pages show the latest-filed value per period.
Public company accounting reference, not market prices, returns, an investment recommendation, or ALPHAC performance. Validate a separately constructed return series with the validation API; accounting values are not returns.
Use this in research
A financial period ends before its results become public. Use the filing date as a minimum availability boundary, inspect amendments, and retain the original filing vintage when testing historical signals. This latest-filed selection can contain information unavailable at the time.
These pages do not supply prices, total-return histories, corporate-action adjustments or a tradable universe. Build those inputs separately before evaluating a strategy. A profitable backtest can still reflect selection bias or costs that were left out.
Research methodology · Execution and cost assumptions · Check backtest overfitting
Build with the open-source tools
Use these accounting records as inspectable inputs. When you have constructed a return series, the validation tools can help test its statistical evidence and preserve the result with its limitations.
- Get an API key and run your first validation
- Connect the MCP server to your coding assistant
- Inspect the ALPHAC engine on GitHub
- Read the MCP server source and integration examples
Read the published dataset with Python
import json
from urllib.request import urlopen
with urlopen("https://canlicapital.com/company-data/0001752828.json") as response:
record = json.load(response)
print(record["fetched_at"])
print(record["policy"])
for concept in record["concepts"]:
print(concept["tag"], next(iter(concept["observations"])))